Institute of Quantitative Systems Pharmacology Iqsp
Public records show a registered, tax-exempt organization in good standing.
What it says it does
IQSP's mission is to advance drug development through instruction in and application of quantitative systems pharmacology
- Income
- $1.2 million
- Spending
- $447,576
- Spent on programs
- 63%
- Reserves
- 14.8 months of spending
- Largest source of income
- donations and private grants, 60%
- Employees
- 1
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Financial health
Strong: 93 out of 100. Higher than 83% of charities in its peer group (education, $1m to $10m).
Reserves
35 of 35Spendable reserves would cover 14.8 months of spending.
Debt
20 of 20It owes 0% of what it owns.
Living within its means
15 of 15Income exceeded spending by 61% of income.
Income trend
15 of 15Income rose 4% on the year before.
Spending floor
8 of 1562% of spending went to programs and raising each dollar of donations cost 0 cents.
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Governance
Fair: 66 out of 100. Higher than 22% of charities in its peer group (education, $1m to $10m).
Independent board
18 of 253 of 3 voting board members are independent.
Conflict of interest policy
15 of 15Has a written conflict of interest policy.
Whistleblower policy
8 of 8Has a written whistleblower policy.
Record keeping policy
7 of 7Has a written policy on keeping and destroying records.
Board minutes
5 of 5Keeps minutes of board meetings.
Board sees the tax return
0 of 10Did not give the board a copy of this return before filing it.
Independent check of accounts
0 of 15Its accounts were not audited or reviewed by an independent accountant.
No reported misuse
10 of 10Reports no diversion of assets, excess benefits or loans to insiders.
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Impact evidence
Describes programs. Its tax return describes what it does but we have found no measurable results in it.
Programs described in its return (1)
- $279,736 spent. High failure rate in drug development is a factor driving up the health care costs in the US and around the world. The Food and Drug Administration (FDA) and National Institutes of Health (NIH) recognize that increased application of computational modeling, often referred to as Model-Informed Drug Development or Quantitative Systems Pharmacology, will be an important factor leading to smarter drug development processes and better decision making. The NIH even issued a White Paper in 2011 naming establishment of research and teaching programs in quantitative systems pharmacology as a national high priority. The FDA, under the 2017 FDA Reauthorization Act, has committed to adopting Model-Informed Drug Development (MIDD) in regulatory consideration of applications for new drugs and generic drugs. Quantitative Systems Pharmacology (QSP) uses computational modeling to gain or enhance understanding of biological systems. MIDD is a sub-area of QSP and refers to using quantitative models to facilitate the decision-making process and address drug development and regulatory questions in four categories: dose optimization, supportive evidence for efficacy, clinical trial design, and informing policy. MIDD is multidisciplinary and requires knowledge in diverse fields including biology, physics, chemistry, pharmacology, pharmaceutical sciences, computational modeling, clinical sciences, and regulatory sciences. IQSP pursues research and training in various areas of QSP and MIDD. Research in support of FDA contract award 75F40119C10139 was
Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate
Legitimacy checks
Is it registered with the IRS? Passed.
Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Has the IRS revoked its tax-exempt status? Passed.
Not on the IRS automatic revocation list.
Source: Automatic revocation of exemption list, Internal Revenue Service, file dated November 6, 2026.
Are donations tax-deductible? Passed.
On the IRS list of organizations eligible to receive tax-deductible contributions.
Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.
Is it keeping up with its IRS filings? Passed.
Most recent return on file covers the year ending December 2024.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
How long has it been tax-exempt? Passed.
Recognized by the IRS since February 2017.
Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.
Is it in good standing with state regulators? Passed.
Not on California's list of charities barred from soliciting. Other states are not yet checked.
Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated November 4, 2026.
Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.